The latest Investing Matters Podcast episode with Inclusive Asset Management's Alexandra McGuigan has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSTP.L Regulatory News (STP)

  • There is currently no data for STP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disposal of Euston House

10 Jan 2019 16:35

RNS Number : 7977M
Stenprop Limited
10 January 2019
 

 

 

STENPROP LIMITED

(Registered in Guernsey)

(Registration number 64865)

LSE share code: STP JSE share code: STP

ISIN: GG00BFWMR296

("Stenprop" or the "Company")

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

DISPOSAL OF EUSTON HOUSE, 24 EVERSHOLT ST, LONDON

10 January 2019

1. Introduction

Shareholders are advised that Stenprop has reached agreement to dispose of its London office building known as Euston House (the "Property") via a sale of all the shares of a special purpose vehicle (the "Property Company") owned by Stenprop to Erel 4 S.a.r.l (the "Buyer"), for a consideration which values the Property at £95 million and which will release cash proceeds of approximately £66.0 million after sales costs, rental top-ups and the repayment of external debt (the "Disposal"). The Buyer is a wholly owned subsidiary of Eurazeo, an investment management business listed on NYSE Euronext Paris, in partnership with investment and asset management business, Arax Properties.

 

Paul Arenson, CEO of Stenprop, said: "The sale of Euston House is the last of our Central London offices to be sold and completes a sales programme of more than £216.6 million of Central London offices. The net proceeds will be used partly to reduce debt and partly to acquire additional multi-let industrial ("MLI") assets in line with our transition strategy into a 100% UK MLI business. Following completion of the sale and before any further MLI acquisitions, the MLI component of our portfolio will represent more than 40% of our total assets and our overall debt will reduce to a loan-to-value ratio of less than 45%. This sale represents another important step in the implementation of our two-year strategic transition plan communicated to shareholders, which envisages being at 65% MLI by 31 March 2020 with no more than 40% overall leverage".

 

2. Rationale for the disposal

Stenprop previously announced its strategic vision to become the leading multi-let Industrial ("MLI") business in the UK. This strategy entails selling all its non-MLI properties over time and utilising the sale proceeds to acquire UK MLI properties which fit its acquisition criteria, and to reduce debt. The disposal of the Property, which is at a £14.5 million premium to its current book value of £80.5 million, is in line with this strategy.

 

The net proceeds from the Disposal will be used to reduce the short-term borrowings used to fund the acquisition of the portfolio of MLI properties announced by Stenprop on 24 December 2018 and to fund further acquisitions in the MLI sector.

 

3. Terms of the disposal

Completion of the Disposal is conditional upon Stenprop carrying out a corporate reorganisation in respect of the entities that hold the Property and Dekabank Deutsche Girozentrale ("Dekabank") consenting to such reorganisation. Completion is expected to occur by no later than 5 April 2019.

 

Failure to complete by this date due in certain circumstances to a default by the Buyer will result in Stenprop (UK) Limited (the "Seller"), a wholly-owned subsidiary of Stenprop, retaining the deposit of 5 million (£4.50 million) which was paid by the Buyer on exchange on 10 January 2019.

 

The Buyer will acquire the Property Company for an aggregate initial consideration of £44.3 million, which is based on the estimated net asset value of the Property Company (the "purchase consideration"), which values the Property at £95 million. In addition, the Buyer will fund the repayment of a shareholder loan owing by the Property Company to the Seller of approximately £22.9 million. The purchase consideration is subject to a further post-completion adjustment to take account of any difference between the actual and the estimated net asset value at completion.

 

Normal warranties and indemnities for a transaction of this nature have been provided by the Seller. However, as the Buyer is proposing to obtain warranty and indemnity insurance, the Seller's liability for breach of general warranties is capped at £1 under the SPA.

 

4. Property specific information

 

Property name

Geographic location

Sector

NLA (sq.ft)

Weighted average rental per square foot (£ psf)

1

Euston House

Central London

Office

112,597

£39.80

 

The value attributable to the Property in Stenprop's consolidated statement of financial position at 30 September 2018 was £80.5 million, being 12% of the total portfolio asset value, and was determined in accordance with Royal Institution of Chartered Surveyors standards by Roger Meeds, a director of Jones Lang LaSalle Limited who is an external valuer registered with the Royal Institution of Chartered Surveyors. This compares with the value derived from the purchase consideration of £95 million. The after-tax EPRA earnings attributable to the special purpose vehicle owning the Property in Stenprop's consolidated statement of comprehensive income for the six months ended 30 September 2018, which was subject to an independent review by Deloitte LLP and prepared under the International Financial Reporting Standards ("IFRS") in accordance with IAS 34 'Interim Financial Reporting', was £1,202,606. The equivalent after tax IFRS earnings were £2,192,955.

 

5. Stenprop portfolio

Following completion of the Disposal, and assuming no further acquisitions, MLI assets will increase from 34% to over 40% of Stenprop's total portfolio, with 54.7% of the total portfolio located in the UK, 42.5% in Germany and 2.8% in Switzerland. Total leverage will reduce from approximately 48% to under 45%.

 

6. Categorisation of the acquisition

The Disposal is classified as a category 2 transaction in terms of the JSE Listings Requirements. Accordingly, it is not subject to approval by shareholders.

 

Stenprop has a primary listing on the Main Board of the JSE and a listing on the Specialist Fund Segment of the Main Market of the LSE.

 

 

For further information:

Stenprop Limited +44(0)20 3918 6600

Paul Arenson

Patsy Watson

Julian Carey

 

Numis Securities Limited (Financial Adviser) +44(0)20 7260 1000

Hugh Jonathan

Vicki Paine

 

Tavistock (PR Adviser) +44(0)20 7920 3150

James Whitmore

James Verstringhe

Kirsty Allan

 

Java Capital Trustees and Sponsors Proprietary Limited +27 (0)11 722 3050

(JSE Sponsor)

About Stenprop:

Stenprop is a Guernsey-registered UK REIT. The objective of the Company is to deliver sustainable growing income to its investors. Stenprop's investment policy is to invest in a diversified portfolio of UK multi-let industrial (MLI) properties with the strategic goal of becoming the leading MLI business in the UK. For further information, go to www.stenprop.com.

MAR

The information contained within this announcement is considered by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No.596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information will be considered to be in the public domain.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DISURSVRKWAAAAR
Date   Source Headline
14th Sep 20219:30 amRNSInvestor Tour
14th Sep 20217:09 amRNSInvestor Tour
13th Sep 20219:00 amRNSResult of AGM
8th Sep 202110:12 amRNSHolding(s) in Company
3rd Sep 20217:00 amRNSGuernsey office sale takes portfolio to 92% MLI
26th Aug 20217:00 amRNSStenprop completes £15.9m double acquisition
12th Aug 20219:00 amRNSResult Of Election For Cash Or Scrip Dividend
6th Aug 202112:00 pmRNSChange To The Total Number Of Voting Rights
6th Aug 20217:00 amRNSCompletion of EUR30.8M Berlin shopping centre sale
3rd Aug 20213:00 pmRNSDirector/PDMR Shareholding
3rd Aug 202112:00 pmRNSHolding(s) in Company
30th Jul 20217:00 amRNSTrading Statement and Rent Collection Update
29th Jul 20212:00 pmRNSPosting Of Notice Of Annual General Meeting
15th Jul 20218:00 amRNSDealings By A Director Of The Company
13th Jul 20219:00 amRNSFinalisation Announcement In Respect Of Election
7th Jul 20213:00 pmRNSChange to the total number of voting rights
7th Jul 20217:00 amRNSStenprop completes £20.6 million Wigan acquisition
6th Jul 20213:00 pmRNSChange to the total number of voting rights
2nd Jul 20212:00 pmRNSScrip Dividend Circular
28th Jun 20212:00 pmRNSChange to the Total number of Voting Rights
24th Jun 20213:00 pmRNSNo Change Statement/ Publication Of Annual Report
22nd Jun 20219:00 amRNSChange to the total number of voting rights
15th Jun 202112:00 pmRNSDirector/PDMR Shareholding
11th Jun 20217:00 amRNSPreliminary results for year ended 31 March 2021
24th May 20219:00 amRNSNotice of Full Year Results
30th Apr 20217:00 amRNSMLI Trading Update Q4 FY21
1st Apr 20217:00 amRNSCompletion of MLI Acquisition & Retail Asset Sales
30th Mar 20219:00 amRNSDirector/PDMR Shareholding
22nd Mar 202110:00 amRNSDirector/PDMR Shareholding
19th Mar 20219:00 amRNSDirector/PDMR Shareholding
9th Mar 20217:00 amRNSAcquisition of three multi-let industrial estates
24th Feb 202110:30 amRNSDirector/PDMR Shareholding
16th Feb 20219:00 amRNSDirector/PDMR Shareholding
11th Feb 202111:00 amRNSResult of election for cash or scrip dividend
9th Feb 202111:00 amRNSTransaction in Own Shares
2nd Feb 20213:00 pmRNSDirector/PDMR Shareholding
29th Jan 20217:00 amRNSMLI Trading Update
22nd Jan 20217:00 amRNSNotice of Quarterly Trading Update
12th Jan 20219:00 amRNSScrip Dividend Circular
7th Jan 202111:00 amRNSDirector/PDMR Shareholding
29th Dec 20207:00 amRNSDisposal of Berlin Shopping Centre for EUR30.8M
22nd Dec 20207:00 amRNSAcquisition of three multi-let industrial estates
21st Dec 20207:00 amRNSDisposal of Victoria Retail Centre for EUR37.45M
17th Dec 20202:00 pmRNSScrip Dividend Circular
15th Dec 20207:00 amRNSStenprop secures new £66.5m debt facility
14th Dec 20202:00 pmRNSDirector/PDMR Shareholding
4th Dec 20207:01 amRNSSummarised Half Year Results
4th Dec 20207:00 amRNSHalf Year Results
2nd Dec 20203:30 pmRNSChanges to the board committees
16th Nov 20209:00 amRNSNotice of Half Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.